SEC. 739.

Aerial transport and Department-wide capability for high-consequence infectious diseases

DIVISION A · TITLE VII: Health Care Provisions · SUBTITLE B: Health Care Administration

Source
SECTION TEXT · SEC. 739.

(a) Requirement

Beginning not later than October 1, 2027, the Secretary of the Air Force, in coordination with the Assistant Secretary of Defense for Health Affairs, the Secretaries of the other military departments, and the Director of the Defense Health Agency, shall carry out a program to provide for the safe, long-range aerial transport of individuals known to be or suspected of infection by high-consequence infectious diseases.

(b) Aerial transport component

The Secretary of Defense shall ensure that the program under subsection (a) serves as the component of the Department of Defense that—

(1)

provides the Department with aerial transport of patients with high-consequence infectious diseases; and

(2)

provides support to other departments and agencies of the Federal Government, State and local governments, and civilian and academic partners, as determined appropriate by the Secretary.

(c) Program requirements

In carrying out the program under subsection (a), the Secretary of the Air Force shall—

(1)

develop and maintain a curriculum, and identify qualified instructors to train and certify military and civilian medical personnel, on procedures associated with the safe, long-range aerial transport of patients with high-consequence infectious diseases;

(2)

establish, and periodically update, medical care standards, infection prevention and control measures, and operational safety protocols necessary to maximize patient survival and minimize infection risk to aircrew, medical personnel, and support personnel;

(3)

serve as the joint force advocate and executive agent within the Department of Defense for aerial transport of individuals with high-consequence infectious diseases;

(4)

establish standards, sustainment requirements, and lifecycle management processes for personal protective equipment, transport isolation systems, and associated medical equipment used in transporting infected patients;

(5)

develop, in coordination with the Joint Staff, joint doctrine, concepts of operation, and medical force requirements necessary to support a Department of Defense-wide high-consequence infectious disease capability, including patient movement, definitive care, and integration across the continuum of care;

(6)

coordinate with the other Secretaries of the military departments and the Director of the Defense Health Agency to inform the organization, training, and equipping of specialized, organized teams capable of conducting high-consequence infectious disease patient movement and care in operational, austere, and strategic environments;

(7)

support interoperability and operational integration with other departments and agencies of the Federal Government, State and local governments, and civilian and academic partners to enable coordinated response to tactical incidents, large-scale contingencies, and research activities related to emerging and future infectious disease threats; and

(8)

identify capability gaps and support research, development, testing, and evaluation of medical countermeasures, transport systems, protective equipment, and operational procedures necessary to improve survivability, safety, and mission effectiveness in high-consequence infectious disease operations.

(d) Enterprise doctrine and oversight

The Secretary of Defense shall develop and maintain Department of Defense-wide doctrine and policy to guide the development, fielding, sustainment, and employment of high-consequence infectious disease response capabilities across the Department.